Pfizer is in the early stage of talks to acquire Seagen (formerly Seattle Genetics), a US biotech focused on developing treatments for cancer, according to a report in...
Safety findings in Phase 2 clinical trials have forced Aristea Therapeutics to stop developing its lead candidate RIST4721 for treating serious immune-mediated...
Two years after European Commission president Ursula von der Leyen and Pfizer CEO Albert Bourla virtually wrapped up a major order for the Covid-19 vaccine Comirnaty that...
Viatris, formed in November 2020 from the merger of Mylan with Pfizer’s Upjohn division, has established an eye care division following the closure of two acquisitions on...
As Covid cases continue to explode across the country, China Meheco Group Co, an internationally active manufacturer and distributor of pharmaceuticals chemicals and...
Pfizer is planning to invest $750 million in its Kalamazoo County, Michigan, production site – one of its biggest – to increase output of injectables and vaccines...
Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...
Pfizer has announced plans to invest more than €1.2 billion at its site in Grange Castle, Dublin, Ireland, to double capacity for biological drug substances.
